Method and device for uterine fibroid treatment
Methods and devices for both imaging and treating uterine fibroid tumors in one real-time system are provided. One minimally invasive method comprises introducing a sheath into a uterus and determining a location of a fibroid using a visualization element within or on the sheath. Upon identification, a portion of the sheath is steered to position at least one treatment needle at the determined location. The needle is then anchored in uterine tissue and the fibroid treated with the needle.
1. A method for treating a uterine fibroid, the method comprising:
introducing a probe transcervically into the uterus;
determining a location of the fibroid using a visualization element on the probe;
deploying a plurality of needles into the fibroid while a real-time image of the fibroid taken using the visualization element is being displayed, wherein the plurality of needles extend away from a location on the probe in a diverging manner into the fibroid; and
treating the fibroid with the plurality of needles;
wherein the visualization element is moveable independent of the plurality of needles.
2. The method of claim 1 , wherein the fibroid is treated by delivering ablative energy with the plurality of needles.
3. The method of claim 2 , wherein the ablative energy is electrical, radiofrequency (RF), laser, microwave, freezing or cryogenic, ultrasound, high frequency ultrasound (HIFU), or radiative.
4. The method of claim 2 , wherein the ablative energy comprises RF energy.
5. The method of claim 1 , wherein the visualization element comprises an ultrasound transducer.
6. The method of claim 5 , wherein the ultrasonic transducer comprises a phased array transducer having 64 elements or a mechanically scanned transducer.
7. The method of claim 1 , wherein the location of the fibroid is determined with the visualization element being located within the uterus.
8. The method of claim 1 , wherein the plurality of needles is coupled to the probe when the probe is introduced transcervically into the uterus.
9. The method of claim 1 , wherein one or more needles of the plurality of needles has an arcuate geometry which resists displacement.
10. The method of claim 1 , wherein one or more needles of the plurality of needles comprise an electrode, antenna, hollow tube, or cutting tube.
11. The method of claim 1 , wherein one or more needles of the plurality of needles is formed from Nitinol.
12. The method of claim 1 , wherein the fibroid is treated by delivering at least one therapeutic agent to the fibroid.
13. The method of claim 1 , wherein the visualization element is steerable, rotatable, deflectable, flexible, pre-shaped, or pre-formed.
14. The method of claim 1 , wherein the plurality of needles consists of two treatment needles.
15. The method of claim 1 , wherein one or more needles of the plurality of needles is self-anchoring.
16. The method of claim 1 , wherein one or more needles of the plurality of needles has a non-linear, arcuate, helical, cork screw, or curved geometry when deployed.
17. The method of claim 1 , further comprising measuring tissue impedance with one or more needles of the plurality of needles.
18. The method of claim 1 , wherein the plurality of needles comprises a first needle and a second needle, wherein the first needle is hollow and has an open distal end, and wherein at least one needle of the plurality of second needles is configured to extend out from the open distal end of the first needle.
19. The method of claim 18 , wherein one or more of (i) the first needle or (ii) the plurality of second needles are deployable from one or more locations on the probe proximal of the visualization element.
20. The method of claim 18 , wherein the first needle and the plurality of second needles are deployable from locations proximal of the visualization element to converge or diverge within the tissue of the fibroid within the field of view of the visualization element.
21. The method of claim 1 , wherein the probe, visualization element, and needle deployment array are integrally formed.
22. The method of claim 1 , wherein the probe, visualization element, and needle deployment array comprise separate, modular components that are coupleable to one another.